An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer is a research paper published in Science Translational Medicine (2025). On theSindex it has a DataRank of 0.360. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: R01 CA042978
NIH HHS
Grant: S10 OD026804
NCI NIH HHS
Grant: P01 CA117969
NCI NIH HHS
Grant: R01 CA175747
NCI NIH HHS
Grant: U01 CA199235
NCI NIH HHS
Grant: P30 CA125123
NCI NIH HHS
Grant: P50 CA196510
NCI NIH HHS
Grant: P01 CA203657
NCI NIH HHS
Grant: R35 CA232113
FWCI
4.23
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords